Theravance Biopharma, Inc. (NASDAQ: TBPH), a dynamic player in the biotechnology sector, is drawing attention with its substantial growth potential, evidenced by an impressive potential upside..
Personalis, Inc. (NASDAQ: PSNL) is carving a niche in the rapidly evolving healthcare sector, specifically within the diagnostics and research industry. With its focus on advanced..
Opthea Limited (NASDAQ: OPT), a biopharmaceutical company headquartered in South Yarra, Australia, has garnered attention in the biotechnology sector for its innovative approach to treating eye..
Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. With a focus on developing novel therapeutics for conditions linked..
For investors with a keen eye on the biotechnology sector, MBX Biosciences, Inc. (NASDAQ: MBX) presents itself as a compelling opportunity. Based in Carmel, Indiana, MBX..
Kura Oncology, Inc. (NASDAQ: KURA) is turning heads in the biotechnology sector with its ambitious portfolio of cancer treatment candidates and a staggering 318% potential upside...
Zenas BioPharma, Inc. (ZBIO) is capturing investor attention with a potential upside of 180.72%, according to recent analyst ratings. As a clinical-stage biopharmaceutical company based in..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) has emerged as a notable player in the biotechnology sector, capturing the attention of investors with its cutting-edge approach to developing..
Surmodics, Inc. (NASDAQ: SRDX) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical devices industry. Despite a challenging financial performance..
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology firm headquartered in South San Francisco, California, is capturing investor attention with a significant potential upside of 149.65%. Operating..
Xencor, Inc. (NASDAQ: XNCR) is capturing attention in the biotech investment landscape with a remarkable potential upside of 266.71%, according to analyst ratings. As a clinical-stage..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing significant investor attention with a staggering potential upside of 398.48%, according to the latest analyst consensus. As a clinical-stage..
Precigen, Inc. (NASDAQ: PGEN), a pioneering entity in the biotechnology sector, is making waves with a remarkable potential upside of 341.01%. This Germantown, Maryland-based company, with..
Valneva SE (VALN), a prominent player in the healthcare sector, specifically within the biotechnology industry, is drawing attention from investors with a promising 111.16% potential upside...
Semler Scientific, Inc. (NASDAQ: SMLR) is an intriguing player in the healthcare sector, specifically within the medical devices industry. Headquartered in Santa Clara, California, the company..
Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage pharmaceutical innovator based in the United Kingdom, is making waves in the biotechnology sector with its pioneering approach to..
Abivax SA (ABVX), a biotechnology company headquartered in Paris, France, is capturing investor attention with its impressive growth potential. Specializing in developing therapeutics that stabilize immune..
Investors seeking opportunities in the biotechnology sector may find Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) an intriguing candidate, thanks to its promising drug pipeline and substantial potential..
In the dynamic world of biotechnology, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands out as a unique player, offering a diverse range of products that significantly..